Joel S. Samuelson

1.2k total citations
32 papers, 887 citations indexed

About

Joel S. Samuelson is a scholar working on Microbiology, Epidemiology and Immunology. According to data from OpenAlex, Joel S. Samuelson has authored 32 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Microbiology, 16 papers in Epidemiology and 8 papers in Immunology. Recurrent topics in Joel S. Samuelson's work include Bacterial Infections and Vaccines (18 papers), Pneumonia and Respiratory Infections (13 papers) and Influenza Virus Research Studies (5 papers). Joel S. Samuelson is often cited by papers focused on Bacterial Infections and Vaccines (18 papers), Pneumonia and Respiratory Infections (13 papers) and Influenza Virus Research Studies (5 papers). Joel S. Samuelson collaborates with scholars based in United States and Finland. Joel S. Samuelson's co-authors include Lance Gordon, Martha L. Lepow, Heikki Peltola, Juhani Eskola, Helena Käyhty, Viena Karanko, P. Helena Mäkelä, Roger M. Barkin, Jack M. Gwaltney and J. Owen Hendley and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The Journal of Immunology.

In The Last Decade

Joel S. Samuelson

32 papers receiving 831 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joel S. Samuelson United States 16 622 567 111 106 83 32 887
Philip P. Vella United States 19 818 1.3× 467 0.8× 184 1.7× 145 1.4× 72 0.9× 26 1.1k
David L. Klein United States 9 627 1.0× 603 1.1× 39 0.4× 25 0.2× 116 1.4× 21 792
A. F. Woodhour United States 14 567 0.9× 158 0.3× 198 1.8× 84 0.8× 78 0.9× 28 807
P. H. Makela Finland 11 531 0.9× 436 0.8× 84 0.8× 87 0.8× 58 0.7× 13 781
Rhonwen Morris United Kingdom 16 1.2k 1.9× 940 1.7× 113 1.0× 30 0.3× 88 1.1× 24 1.3k
Dominique Boutriau Belgium 21 784 1.3× 765 1.3× 90 0.8× 35 0.3× 168 2.0× 37 1.0k
G Bjune Norway 19 1.5k 2.5× 1.6k 2.8× 240 2.2× 98 0.9× 233 2.8× 29 1.9k
ChrisAnna M. Mink United States 16 857 1.4× 801 1.4× 99 0.9× 80 0.8× 176 2.1× 27 1.0k
Rose‐Marie Ölander Finland 18 561 0.9× 496 0.9× 153 1.4× 40 0.4× 212 2.6× 23 871
Peter C. Giardina United States 21 747 1.2× 404 0.7× 195 1.8× 102 1.0× 159 1.9× 55 1.2k

Countries citing papers authored by Joel S. Samuelson

Since Specialization
Citations

This map shows the geographic impact of Joel S. Samuelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel S. Samuelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel S. Samuelson more than expected).

Fields of papers citing papers by Joel S. Samuelson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel S. Samuelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel S. Samuelson. The network helps show where Joel S. Samuelson may publish in the future.

Co-authorship network of co-authors of Joel S. Samuelson

This figure shows the co-authorship network connecting the top 25 collaborators of Joel S. Samuelson. A scholar is included among the top collaborators of Joel S. Samuelson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel S. Samuelson. Joel S. Samuelson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Frank, Arthur L., Richard Labotka, Patrick H. McVerry, et al.. (1988). Haemophilus influenzae Type b Immunization of Children With Sickle Cell Diseases. PEDIATRICS. 82(4). 571–575. 20 indexed citations
3.
Berkowitz, Carol D., Joel I. Ward, J. Owen Hendley, et al.. (1987). Safety and immunogenicity of Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children 15 to 24 months of age. The Journal of Pediatrics. 110(4). 509–514. 36 indexed citations
4.
Eskola, Juhani, Heikki Peltola, Aino K. Takala, et al.. (1987). Efficacy ofHaemophilus IinfluenzaeType b Polysaccharide–Diphtheria Toxoid Conjugate Vaccine in Infancy. New England Journal of Medicine. 317(12). 717–722. 208 indexed citations
5.
Käyhty, Helena, Juhani Eskola, Heikki Peltola, et al.. (1987). Immunogenicity in Infants of a Vaccine Composed of Haemophilus influenzae Type b Capsular Polysaccharide Mixed with DPT or Conjugated to Diphtheria Toxoid. The Journal of Infectious Diseases. 155(1). 100–106. 60 indexed citations
6.
Barkin, Roger M., J. Owen Hendley, John M. Zahradnik, Patrick H. McVerry, & Joel S. Samuelson. (1987). Capsular polysaccharide Haemophilus influenzae type b vaccine. The Pediatric Infectious Disease Journal. 6(1). 20–23. 1 indexed citations
7.
Pichichero, Michael E., Roger M. Barkin, & Joel S. Samuelson. (1986). Pediatric diphtheria and tetanus toxoids-adsorbed vaccine. The Pediatric Infectious Disease Journal. 5(4). 428–430. 11 indexed citations
8.
9.
Samuelson, Joel S.. (1985). An accurate photographic method for grading acne: Initial use in a double-blind clinical comparison of minocycline and tetracycline. Journal of the American Academy of Dermatology. 12(3). 461–467. 38 indexed citations
10.
Lepow, Martha L., Roger M. Barkin, John M. Zahradnik, et al.. (1985). 1134 STUDIES OF SAFETY AND IMMUNOGENICITY OF HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE VACCINE (PRP-D) IN CHILDREN 7–14 MONTHS OF AGE. Pediatric Research. 19(4). 299A–299A. 1 indexed citations
11.
Eskola, Juhani, Heikki Peltola, P. Helena Mäkelä, et al.. (1985). ANTIBODY LEVELS ACHIEVED IN INFANTS BY COURSE OF HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE/DIPHTHERIA TOXOID CONJUGATE VACCINE. The Lancet. 325(8439). 1184–1186. 88 indexed citations
12.
Bernbaum, Judy, Robert Anolik, Joel S. Samuelson, et al.. (1985). Response of preterm infants to diphtheria-tetanus-pertussis immunizations. The Journal of Pediatrics. 107(2). 184–188. 67 indexed citations
13.
Lepow, Martha L., Joel S. Samuelson, & Lance Gordon. (1985). Safety and immunogenicity of haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of age. The Journal of Pediatrics. 106(2). 185–189. 53 indexed citations
14.
Barkin, Roger M., et al.. (1985). Pediatric diphtheria and tetanus toxoids vaccine: Clinical and immunologic response when administered as the primary series. The Journal of Pediatrics. 106(5). 779–781. 3 indexed citations
15.
Barkin, Roger M., et al.. (1984). DTP reactions and serologic response with a reduced dose schedule. The Journal of Pediatrics. 105(2). 189–194. 26 indexed citations
16.
Samuelson, Joel S.. (1981). Acne Grading Methods. Archives of Dermatology. 117(5). 252–252. 1 indexed citations
17.
Kraft, Sumner C., Joel S. Samuelson, & Richard S. Farr. (1967). Acriflavine-induced immunological paralysis: the effect of varying antigen doses.. PubMed. 12(1). 53–62. 1 indexed citations
18.
Samuelson, Joel S., P. Brian Stewart, Sumner C. Kraft, & Richard S. Farr. (1965). The Effectiveness of Acriflavine and Ineffectiveness of Proflavine as Immunosuppressant Agents. The Journal of Immunology. 95(2). 314–322. 4 indexed citations
19.
Samuelson, Joel S., Sumner C. Kraft, & Richard S. Farr. (1965). The Contrasting Immunosuppressant Effects of Acriflavine and Dietary Restriction. The Journal of Immunology. 95(6). 1013–1022. 4 indexed citations
20.
Samuelson, Joel S., Ben Fisher, & Edward A. Fisher. (1965). 1963. Prolonged survival of skin homografts in dogs with thoracic duct fistulas. Transplantation. 3(1). 126–126. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip P. Vella Breakdown of academic impact, for papers by David L. Klein Breakdown of academic impact, for papers by A. F. Woodhour Breakdown of academic impact, for papers by P. H. Makela Breakdown of academic impact, for papers by Rhonwen Morris Breakdown of academic impact, for papers by Dominique Boutriau Breakdown of academic impact, for papers by G Bjune Breakdown of academic impact, for papers by ChrisAnna M. Mink Breakdown of academic impact, for papers by Rose‐Marie Ölander Breakdown of academic impact, for papers by Peter C. Giardina
Rankless by CCL
2026